Company: HCWB
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-283238
Chunk: 10

Company: HCW Biologics Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 6
Chunk 10
---
 May 29, 2025, between the Company and Wugen, Inc.
     10-Q
     011-40591
     10.17
     08/18/2025

     10.18
     First Amendment to the Equity Purchase Agreement, dated August 14, 2025, between the Company and Square Gate Master Fund – Series 4.
     8-K
     011-40591
     10.1
     08/15/2025

     31.1
     Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 

     X

     31.2
     Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 

     X

     32.1*
     Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 

     X